Unilever is to acquire Horlicks and a clutch of other health drink brands in India from drugs maker Glaxosmithkline (GSK) for 3.3 billion euros (£2.94 billion). Unilever is to acquire Horlicks and a clutch of other health drink brands in India from drugs maker Glaxosmithkline (GSK) for 3.3 billion euros (£2.94 billion). GSK’s listed Indian consumer healthcare business will be merged with Hindustan Unilever Limited (HUL), forming one of the largest food and refreshment groups in the country. The deal will give GSK a 5.7% stake in the resulting company which it intends to sell off in tranches. GSK India’s brands include Horlicks and Boost.

Source: Irish Independent December 03, 2018 10:20 UTC